×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
CSPC Pharmaceutical Group (HKG:1093) Has Announced A Dividend Of CN¥0.14
Simply Wall Street
CSPC Pharmaceutical Group Limited's ( HKG:1093 ) investors are due to receive a payment of CN¥0.14 per share on 26th of...
1 day ago
Bearish block trade of CSPC PHARMA(01093) 774K shares at $6.51, $5.039M turnover
AASTOCKS.com
[Block Trade] A bearish block trade of 774K shares of CSPC PHARMA(01093) occurred at price of HK$6.51 and turnover of HK$5.039M at 03:05p.m...
9 hours ago
China's CSPC Pharma partners with Pfizer for oral COVID treatment
Reuters
Chinese drug maker CSPC Pharmaceutical Group said on Thursday it signed a strategic partnership with Pfizer to launch a local brand of an...
10 months ago
CSPC's bispecific fusion protein drug JMT-106 gains US IND clearance for GPC3-positive solid tumors
BioWorld MedTech
CSPC Pharmaceutical Group Ltd. has announced FDA approval of an IND application for JMT-106, a bispecific fusion protein drug,...
4 months ago
Pfizer, China Drugmaker Partner to Sell Local Brand of Paxlovid
Bloomberg
Pfizer has struck a deal with Chinese drugmaker CSPC Pharmaceutical Group Ltd. to launch a local brand of Covid-19 antiviral Paxlovid,...
10 months ago
CSPC Pharmaceutical Group Full Year 2023 Earnings: Misses Expectations
Simply Wall Street
CSPC Pharmaceutical Group ( HKG:1093 ) Full Year 2023 Results Key Financial Results Revenue: CN¥31.5b (up 1.7% from FY...
1 month ago
CSPC Pharma (HKG: 1093) up 11.5% - testing permission for the cancer drug
Dhaka Tribune
CSPC Pharmaceuticals (HKG: 1093) shares are up 11.5% in Hong Kong today. The cause here seems to be the approval to start testing of a new...
6 months ago
China's drugmakers can't sell mRNA shots but haven't quit yet
ET HealthWorld
MRNA Vaccines: CSPC's first shot faced limited distribution by health authorities, partly because it did not target a more recent variant or...
1 month ago
CSPC Pharma partners with Pfizer for oral COVID-19 treatment in China
BioSpectrum Asia
CSPC Pharma partners with Pfizer for oral COVID-19 treatment in China.
10 months ago
Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner ...
PR Newswire
Initial data showed promising signs of efficacy, including a 47.1% ORR in patients with resistant/refractory gastric cancer expressing...
11 months ago